
2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation
- Author
- Jeroen Verhoeven (UGent) , Tristan Baguet, Sarah Piron, Glenn Pauwelyn, Charlotte Bouckaert, Benedicte Descamps (UGent) , Robrecht Raedt (UGent) , Christian Vanhove (UGent) , Filip De Vos (UGent) and Ingeborg Goethals (UGent)
- Organization
- Keywords
- Molecular Medicine, Cancer Research, Radiology Nuclear Medicine and imaging, RECURRENT BRAIN-TUMOR, O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET, F-18-FDG PET, DIFFERENTIATING RECURRENT, C-11-METHIONINE PET, FDG, SENSITIVITY, GLIOMA, TOMOGRAPHY, DIAGNOSIS
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.59 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8639046
- MLA
- Verhoeven, Jeroen, et al. “2-[18F]FELP, a Novel LAT1-Specific PET Tracer, for the Discrimination between Glioblastoma, Radiation Necrosis and Inflammation.” NUCLEAR MEDICINE AND BIOLOGY, vol. 82–83, 2020, pp. 9–16, doi:10.1016/j.nucmedbio.2019.12.002.
- APA
- Verhoeven, J., Baguet, T., Piron, S., Pauwelyn, G., Bouckaert, C., Descamps, B., … Goethals, I. (2020). 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. NUCLEAR MEDICINE AND BIOLOGY, 82–83, 9–16. https://doi.org/10.1016/j.nucmedbio.2019.12.002
- Chicago author-date
- Verhoeven, Jeroen, Tristan Baguet, Sarah Piron, Glenn Pauwelyn, Charlotte Bouckaert, Benedicte Descamps, Robrecht Raedt, Christian Vanhove, Filip De Vos, and Ingeborg Goethals. 2020. “2-[18F]FELP, a Novel LAT1-Specific PET Tracer, for the Discrimination between Glioblastoma, Radiation Necrosis and Inflammation.” NUCLEAR MEDICINE AND BIOLOGY 82–83: 9–16. https://doi.org/10.1016/j.nucmedbio.2019.12.002.
- Chicago author-date (all authors)
- Verhoeven, Jeroen, Tristan Baguet, Sarah Piron, Glenn Pauwelyn, Charlotte Bouckaert, Benedicte Descamps, Robrecht Raedt, Christian Vanhove, Filip De Vos, and Ingeborg Goethals. 2020. “2-[18F]FELP, a Novel LAT1-Specific PET Tracer, for the Discrimination between Glioblastoma, Radiation Necrosis and Inflammation.” NUCLEAR MEDICINE AND BIOLOGY 82–83: 9–16. doi:10.1016/j.nucmedbio.2019.12.002.
- Vancouver
- 1.Verhoeven J, Baguet T, Piron S, Pauwelyn G, Bouckaert C, Descamps B, et al. 2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation. NUCLEAR MEDICINE AND BIOLOGY. 2020;82–83:9–16.
- IEEE
- [1]J. Verhoeven et al., “2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation,” NUCLEAR MEDICINE AND BIOLOGY, vol. 82–83, pp. 9–16, 2020.
@article{8639046, author = {{Verhoeven, Jeroen and Baguet, Tristan and Piron, Sarah and Pauwelyn, Glenn and Bouckaert, Charlotte and Descamps, Benedicte and Raedt, Robrecht and Vanhove, Christian and De Vos, Filip and Goethals, Ingeborg}}, issn = {{0969-8051}}, journal = {{NUCLEAR MEDICINE AND BIOLOGY}}, keywords = {{Molecular Medicine,Cancer Research,Radiology Nuclear Medicine and imaging,RECURRENT BRAIN-TUMOR,O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET,F-18-FDG PET,DIFFERENTIATING RECURRENT,C-11-METHIONINE PET,FDG,SENSITIVITY,GLIOMA,TOMOGRAPHY,DIAGNOSIS}}, language = {{eng}}, pages = {{9--16}}, title = {{2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation}}, url = {{http://doi.org/10.1016/j.nucmedbio.2019.12.002}}, volume = {{82-83}}, year = {{2020}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: